Surrozen (SRZN) FCF Margin (2024 - 2026)
Surrozen (SRZN) posted quarterly FCF Margin of 252.4% for Q1 2026, up 69429.0% year-over-year from N/an in Q1 2025, and up 77.42% quarter-over-quarter from 1117.99% in Q4 2025.
Surrozen (SRZN) FCF Margin (2024 - 2026) Analysis & Trends
Surrozen's FCF Margin history runs 3 years deep, the most recent figure standing at 252.4% for Q1 2026.
- In Q1 2026, FCF Margin rose 69429.0% year-over-year to 252.4%; the TTM figure through Mar 2026 stood at 449.51% (down 29345.0% YoY), while the FY2025 annual figure was 873.51%, down 70825.0% from the prior year.
- FCF Margin for Q1 2026 stood at 252.4%, up from 1117.99% in the prior quarter.
- The five-year high for FCF Margin was 534.05% in Q4 2024, with the low at 1117.99% in Q4 2025.
- The 3-year median for FCF Margin is 624.52% (2025), against an average of 484.71%.
- The sharpest annual moves came in 2025 and 2026: FCF Margin slumped 165204 bps in 2025, then jumped 69429 bps in 2026.
- Surrozen's FCF Margin stood at 534.05% in 2024, then slumped by 309 bps to 1117.99% in 2025, then surged by 77 bps to 252.4% in 2026.
- Business Quant data shows SRZN's FCF Margin at 252.4% in Q1 2026, 1117.99% in Q4 2025, and 918.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - | -148.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -148.58% |
| Mar 31, 2026 | -252.40% |
| Dec 31, 2025 | -1,117.99% |
| Sep 30, 2025 | -918.01% |
| Jun 30, 2025 | -624.52% |
| Mar 31, 2025 | -946.69% |
| Dec 31, 2024 | 534.05% |
| Sep 30, 2024 | -67.43% |